PRESENTATIONNATION

PRESENTATIONNATION

Browse a growing database of presentations shared by companies worldwide.

Browse

Browse All
All Companies
Presentations
Infographics
Reports
Brochures

Company

Blog
About
Contact

Legal

Privacy Policy
Terms of Service

© 2026 Presentation Nation. All rights reserved.
Built in San Diego by Twenty6 Red, Inc.

Stora Enso_April_2020_11_54011 - Stora Enso | Presentation Nation

HomepageStora EnsoStora Enso_April_2020_11_54011

Stora Enso_April_2020_11_54011

Stora Enso

Browse presentations, reports, and documents from Stora Enso.

Tags

2020

Filter options

All (32)●
brochure (2)○
earnings (2)○
investor_presentation (2)○
presentation (26)○

Get the best presentations in your inbox

Join professionals who get a weekly curated collection of top business presentations, investor decks, and industry reports — free.

No spam. Unsubscribe anytime.

Loading viewer...

presentation

Format: PDF presentation

Share:

Stora Enso_April_2020_11_54011 by Stora Enso.

Browse all presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Stora Enso

Stora%20Enso%20case%20study.pdf.downloadasset

brochure

Stora%20Enso%20Plastics%20Case%20Study.pdf.downloadasset

brochure

Similar presentations from other companies

AmericanBatteryTechnologyCompany_Presentation_Jan22_2024

presentation

American Battery Technology Company

Securitas_January_2021_636_75636

presentation

Securitas

Stora Enso 2021 Roadshow Presentation: Growth and Value Strategy

investor_presentation

investor_presentation

35 Pages

Stora Enso__2023__452_90452

presentation

Stora Enso__2023__562_94562

presentation

Stora Enso__2023__728_96728

presentation

EC_Company-Presentation_NEW-Impressions-Hall-1_20210210

presentation

EURO-COMPOSITES® GROUP

American Express_January_2018_858_19858

presentation

American Express Company

66b4d0c02e4d36f5ba341581_Qtr_Q1%20FY25%20Investor%20Presentation

presentation

Filatex Limited

CRISPR-Tx-Corporate-Overview-Q4-2021

presentation

CRISPR Therapeutics